Product Details
Novo-Rythro Ethyl Succinate
Erythromycin Ethylsuccinate40 mg/mL
Oral Liquid
DIN/PIN/NPN
00605859
Manufacturer
Novopharm Ltd.
Formulary Listing Date
1996-10-01
Unit Price
0.0669
Amount MOH Pays
0.0669
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Antibiotics, Erythromycins (8:12:12): Erythromycin alone is not adequate for the treatment of H. influenzae infections. It lacks consistently reliable activity against this organism. Erythromycin is a potent inhibitor of hepatic oxidation of some drugs and may cause significant elevation of blood levels of astemizole, carbamazepine, cyclosporine, digoxin, dihydropyridines, terfenadine, theophylline and warfarin. Potentially fatal arrhythmias (torsade de pointes) can occur with the combination of erythromycin and astemizole or terfenadine.
ATC Code
J01FA01
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 00605859 | Novo-Rythro Ethyl Succinate | 0.0669 | 0.0669 |
| 00000299 | EES-200 | NA | NA |